-
SunTrust Continues To See Upside Potential In Netflix's Q3
Monday, September 17, 2018 - 2:55pm | 355Read More...The bullish case for streaming video platform Netflix, Inc. (NASDAQ: NFLX) remains unchanged after the latest round of monthly data showed encouraging subscriber growth trends, according to SunTrust Robinson Humphrey. The Analyst Analyst Matthew Thornton maintained a Buy rating on...
-
Buy Netflix On The Pullback, SunTrust Says
Friday, August 24, 2018 - 1:42pm | 311Read More...Shares of Netflix, Inc. (NASDAQ: NFLX) peaked just shy of the $425 level earlier this summer and with shares trading lower by nearly $75, investors may want to take advantage of the sell-off. The Analyst SunTrust Robinson Humphrey's Matthew Thornton upgraded Netflix from Hold to Buy but with a...
-
WildHorse's Decline 'Makes Little Sense,' SunTrust Says In Upgrade
Thursday, August 9, 2018 - 1:07pm | 360Read More...Wildhorse Resource Development Corp (NYSE: WRD), is a single-basin story and pure-play NE Eagle Ford company whose stock sold off Wednesday for no legitimate reason, according to SunTrust. The Analyst SunTrust Robinson Humphrey's Welles Fitzpatrick upgraded WildHorse Resource Development from...
-
SunTrust Upgrades Baker Hughes After 'Several Solid Quarters'
Tuesday, July 24, 2018 - 3:24pm | 329Read More...Better-than-expected second-quarter operating income has improved SunTrust Robinson Humphrey's optimism regarding Baker Hughes A GE Co (NYSE: BHGE)’s earnings power. The Analyst Analyst Ken Sill upgraded Baker Hughes from Hold to Buy and raised the stock’s price...
-
Improving Starz Content Prompts SunTrust To Turn Bullish On Lions Gate
Thursday, July 19, 2018 - 3:47pm | 326Read More...Shares of Lions Gate Entertainment Corp. (NYSE: LGF-A) (NYSE: LGF-B) are likely to move higher over the coming quarters as investors better appreciate Starz's contribution, according to SunTrust. The Analyst SunTrust Robinson Humphrey's Matthew Thornton upgraded Lions Gate from Neutral to...
-
Achaogen In The Spotlight Ahead of FDA Verdict On Plazomicin
Friday, June 22, 2018 - 4:16pm | 858Read More...Achaogen Inc (NASDAQ: AKAO) shares have been rangebound between $10 and $14 since late last year, with a mixed FDA panel vote on its antibiotic treatment candidate plazomicin in early May stifling any potential rally. Update: On June 26, the FDA approved Achaogen's antibiotic for urinary tract...
-
NXP Semiconductors' Standalone Value Is $119, SunTrust Says In Downgrade
Monday, June 11, 2018 - 12:17pm | 434Read More...Assuming the Qualcomm, Inc. (NASDAQ: QCOM) tie-up with NXP Semiconductors NV (NASDAQ: NXPI) ultimately fails to be approved by Chinese regulators, NXP's stock is worth $119 per share on a standalone basis, according to SunTrust Robinson Humphrey. The Analyst Analyst William Stein...
-
Down 26% In 2018, LKQ Is Far From 'Totaled,' Says Bullish SunTrust Analyst
Wednesday, May 30, 2018 - 3:03pm | 372Read More...Auto parts distributor LKQ Corporation (NYSE: LKQ)'s stock fell 26 percent in 2018, but investors who think the stock is "totaled" may want to reconsider, according to SunTrust Robinson Humphrey. The Analyst Analyst Stephanie Benjamin initiated coverage of LKQ's stock with...
-
Why Achaogen Shares Are Getting Crushed On Plazomicin FDA News
Thursday, May 3, 2018 - 11:03am | 481Read More...Achaogen Inc (NASDAQ: AKAO) shares are tumbling Thursday after a mixed FDA panel vote on Plazomicin, its lead candidate to treat serious bacterial infections due to multidrug-resistant enterobacteriaceae. Achaogen shares were slumping 25.3 percent to $10.98 at the time of publication....
-
Analyst: Schlumberger Is A Strong Oilfield Stock In Down Markets
Tuesday, April 3, 2018 - 11:53am | 329Read More...With the shares of Schlumberger Limited. (NYSE: SLB) trading just 4 percent above their 2016 lows, an analyst at SunTrust Robinson Humphrey said the weakness is a buying opportunity. The Analyst Analyst Ken Sill upgraded shares of Schlumberger from Hold to Buy and maintained an $80...
-
SunTrust: Why HD Supply Could Hit $48 Per Share
Thursday, March 15, 2018 - 3:09pm | 382Read More...Shares of HD Supply Holdings Inc (NASDAQ: HDS) have lost more than 8 percent over the past year, but the bullish case for owning the stock can now be made, according to SunTrust. The Analyst SunTrust Robinson Humphrey's Keith Hughes upgraded HD Supply Holdings' stock from Hold to Buy...
-
Paylocity Notches Upgrade On Projections Of Sustained Revenue Growth
Monday, March 12, 2018 - 4:16pm | 352Read More...Paylocity Holding Corp (NASDAQ: PCTY), a cloud-based payroll processor, is an attractive asset with nice line-of-sight into $1 billion in annualized revenues and 30-percent-plus adjusted EBITDA margins in the long term, according to SunTrust Robinson Humphrey. The Analyst SunTrust Robinson...
-
Leverage, Weak Guidance Could Put Pressure On Whitestone Dividends, Analyst Says
Friday, March 2, 2018 - 1:59pm | 255Read More...High leverage and weak 2018 guidance could put pressure on Whitestone REIT (NYSE: WSR)’s dividend policy, according to analysts at Suntrust Robinson Humphrey. The Analyst Ki Bin Kim Of Suntrust Robinson Humphrey downgraded Whitestone from Hold to Sell, lowering the REIT’s price target...
-
Microchip Technology Notches Upgrade After Microsemi Purchase
Friday, March 2, 2018 - 11:50am | 441Read More...Microchip Technology Inc. (NASDAQ: MCHP), a specialized semiconductor company, reached an agreement Thursday to acquire Microsemi Corporation (NASDAQ: MSCC), the largest supplier of military and aerospace semiconductor equipment. The deal reinforces Microchip's core strategy and justifies...
-
2 Gene Editing Stocks SunTrust Recommends
Tuesday, January 23, 2018 - 4:50pm | 535Read More...Gene editing refers to the process of insertion, deletion or replacement of DNA at a specific site in the genome of an organism or cell. Investors have a few opportunities to gain exposure to companies that operate in this field, two of which analysts at SunTrust Robinson Humphrey hold a bullish...














